Community-reported Tarceva side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Tarceva Side Effect Episode
Have You dealt with a Tarceva side effect? Share your experience
Review Tarceva Safety Reports submitted to FDA
Total Tarceva reports: 303.Tarceva FDA safety alerts: No.
Reported deaths: 108 Reported hospitalizations: 142.
Take Tarceva Side Effects Survey, Discuss Tarceva with others
FDA Reported Tarceva Side Effects: diarrhoea, fatigue, dry skin, dehydration, malignant neoplasm progression, cough, respiratory failure, nausea, haemoptysis, rash, rash pustular.
Tarceva Usage.
If you have questions about Tarceva, you can ask a Health Expert or Ask Patient Community about Tarceva.
< Previous Showing 201-300 of 303 Next >
Tarceva Side Effects Report #5472453-1Physician from CHINA reported TARCEVA problem on Sept 11, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with INSULIN. Patient recovered.
Tarceva Side Effects Report #5472454-3
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on Sept 11, 2007. Female patient, 55 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, malignant neoplasm progression, platelet count decreased, respiratory failure, white blood cell count decreased. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with PROPOXYPHEN NAPSYLATE, ZOLPIDEM TARTRATE, DILANTIN KAPSEAL, MANNITOL. Patient died on 08/31/2007.
Tarceva Side Effects Report #5473209-6
Physician from FRANCE reported TARCEVA problem on Sept 12, 2007. Male patient, 50 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. TARCEVA dosage: unknown. During the same period patient was treated with SKENAN. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5474734-4
TARCEVA problem was reported by a Physician from BELGIUM on Sept 13, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hyperkalaemia, nausea, vomiting. TARCEVA dosage: unknown. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5474887-8
Physician from FRANCE reported TARCEVA problem on Sept 13, 2007. Male patient was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: epilepsy. TARCEVA dosage: unknown. During the same period patient was treated with DI ANTALVIC, LEVOTHYROXINE, NEURONTIN, AMARYL, IRBESARTAN, PREVISCAN. Patient recovered.
Tarceva Side Effects Report #5404737-7
TARCEVA problem was reported by a Consumer or non-health professional from CANADA on July 17, 2007. Male patient, 71 years of age, was treated with TARCEVA. TARCEVA dosage: unknown. Patient died on 05/06/2007.
Tarceva Side Effects Report #5405699-9
Physician from UNITED STATES reported TARCEVA problem on May 23, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cataract operation, cervical vertebral fracture, fall, impaired healing, syncope. TARCEVA dosage: unknown. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5407464-5
TARCEVA problem was reported by a Physician from FRANCE on July 19, 2007. Male patient, 48 years of age, was diagnosed with bronchial carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, no therapeutic response, pulmonary fibrosis, rash, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 06/26/2007.
Tarceva Side Effects Report #5407967-3
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on July 20, 2007. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, intestinal obstruction, pneumonia, rash pustular, thirst, vomiting. TARCEVA dosage: unknown. During the same period patient was treated with SENNA C, DIGOXIN, CARDIZEM, ATENOLOL, COMPAZINE, COUMADIN. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5408505-1
TARCEVA problem was reported by a Physician from UNITED STATES on July 20, 2007. Female patient, 46 years of age, was diagnosed with adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: klebsiella sepsis, pneumonitis, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #5409382-5
Physician from CHINA reported TARCEVA problem on July 30, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: disease progression, haemoptysis, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 06/28/2007.
Tarceva Side Effects Report #5409388-6
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on July 23, 2007. Female patient, 55 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, white blood cell count decreased. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with PROPDXYPHEN NAPSYLATE, ZOLPIDEM TARTRATE, DILANTIN KAPSEAL, MANNITOL. Patient recovered.
Tarceva Side Effects Report #5411147-5
Physician from KOREA, REPUBLIC OF reported TARCEVA problem on July 24, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with MEGESTROL ACETATE, MYCOPHENOLIC ACID, ALFUZOSIN, DEFLAZACORT. Patient died on 12/11/2006.
Tarceva Side Effects Report #5413050-3
TARCEVA problem was reported by a Physician from GERMANY on July 25, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiovascular disorder, convulsion, gastrointestinal haemorrhage, respiratory failure, shock haemorrhagic, ventricular fibrillation. TARCEVA dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMZAR, METOPROLOL TARTRATE. Patient died.
Tarceva Side Effects Report #5413055-2
Consumer or non-health professional from CHINA reported TARCEVA problem on July 25, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with INSULIN. Patient recovered.
Tarceva Side Effects Report #5413294-0
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on July 27, 2007. Male patient, 41 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, haemoptysis, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5417864-5
Physician from FRANCE reported TARCEVA problem on July 31, 2007. Male patient, 49 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pulmonary fibrosis, rash, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with TRANXENE, ESMEPRAZOLE, FLECAINIDE ACETATE, VERAPAMIL. Patient was hospitalized. Patient died on 06/26/2007.
Tarceva Side Effects Report #5420735-1
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on Aug 01, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, disease progression, dyspnoea, respiratory failure, tachypnoea. TARCEVA dosage: 150 MG (QD), ORAL. Patient died on 07/21/2007.
Tarceva Side Effects Report #5420774-0
Physician from GERMANY reported TARCEVA problem on Aug 01, 2007. Female patient, 63 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: anaemia of malignant disease, blood thyroid stimulating hormone increased, breast mass, breast neoplasm, cellulitis, haemoptysis, hypokalaemia, hyponatraemia, metastases to lung. TARCEVA dosage: 150 MG (QD),ORAL. During the same period patient was treated with PREDNISOLONE, HYDROCHLOROTHIAZIDE, PANTOZOL, LEVOTHYROXINE, MOVICOL, IBUPROFEN, TOREM, MORPHINE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5422997-3
TARCEVA problem was reported by a Health Professional from SPAIN on Aug 03, 2007. Male patient, 77 years of age, was diagnosed with respiratory tract neoplasm and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypokalaemia, renal failure acute. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5422998-5
Physician from CHINA reported TARCEVA problem on Aug 03, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cough, disease progression, haemoptysis, pyrexia, respiratory failure, white blood cell count increased. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #5423043-8
TARCEVA problem was reported by a Health Professional from UNITED STATES on Aug 20, 2007. Female patient, 43 years of age, weighting 188.5 lb, was diagnosed with metastases to central nervous system, non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cellulitis, headache, hypoxia, lung adenocarcinoma, metastases to central nervous system, pleural effusion, positron emission tomogram abnormal, pyrexia. TARCEVA dosage: 150MG P.O QDAY. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5423121-3
Physician from BRAZIL reported TARCEVA problem on Aug 06, 2007. Male patient, 57 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haemothorax, interstitial lung disease, lung neoplasm malignant, malignant neoplasm progression, no therapeutic response, pleural haemorrhage. TARCEVA dosage: 150 MG (QD),ORAL. Patient was hospitalized. Patient died on 07/22/2007.
Tarceva Side Effects Report #5424198-1
TARCEVA problem was reported by a Physician from ARGENTINA on Aug 07, 2007. Male patient, 43 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: rash. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5424261-5
Physician from ARGENTINA reported TARCEVA problem on Aug 07, 2007. Male patient, 67 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, rash. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5424440-7
TARCEVA problem was reported by a Physician from ARGENTINA on Aug 07, 2007. Male patient, 57 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: asthenia. TARCEVA dosage: 150 MG QD ORAL. Patient died.
Tarceva Side Effects Report #5424576-0
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on Aug 07, 2007. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, diarrhoea, faeces discoloured, haemoglobin decreased, pain, pyrexia, rash, skin exfoliation, skin ulcer. TARCEVA dosage: 150 MG (QD), ORAL; 75 MG (QD),ORAL. During the same period patient was treated with ASPIRIN, TRIAMCINOLONE, MAMYX, CALMOSEPTINE, CLONIDINE, TOPROL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5426031-0
TARCEVA problem was reported by a Health Professional from UNITED STATES on Aug 24, 2007. Female patient, weighting 135.0 lb, was diagnosed with breast cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: fatigue, peripheral coldness. TARCEVA dosage: 150MG ONCE QD PO. During the same period patient was treated with LETROZOLE, NEXIUM, COMPAZINE, FERROUS SULPHATE, LORTAB. Patient died on 08/14/2007.
Tarceva Side Effects Report #5427699-5
Consumer or non-health professional from CANADA reported TARCEVA problem on Aug 08, 2007. Male patient, 59 years of age, was treated with TARCEVA. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5427704-6
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on Aug 08, 2007. Female patient, 55 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, white blood cell count decreased. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with PROPOXYPHEN NAPSYLATE, ZOLPIDEM TARTRATE, DILANTIN KAPSEAL, MANNITOL. Patient recovered.
Tarceva Side Effects Report #5431641-0
Pharmacist from UNITED STATES reported TARCEVA problem on Aug 13, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haemoptysis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5441533-9
TARCEVA problem was reported by a Health Professional from UNITED STATES on Aug 30, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cellulitis. TARCEVA dosage: 150 MG QD PO. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5442883-2
Physician from UNITED STATES reported TARCEVA problem on Aug 31, 2007. Male patient, 61 years of age, weighting 135.0 lb, was diagnosed with squamous cell carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: aspiration, asthenia, blood albumin decreased, blood potassium decreased, breakthrough pain, breath odour, bronchopleural fistula, cerebral atrophy, constipation. TARCEVA dosage: 150MG PO QD. During the same period patient was treated with INTRA ARTERIAL CISPLATIN. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5442909-6
TARCEVA problem was reported by a Health Professional from UNITED KINGDOM on Aug 16, 2007. Male patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cerebral thrombosis. TARCEVA dosage: 100 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5443309-5
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on Aug 31, 2007. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: motor dysfunction, muscular weakness, neuropathy, pyrexia. TARCEVA dosage: 400MG DAILY ORAL. During the same period patient was treated with RAPAMUNE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5376145-9
TARCEVA problem was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, 68 years of age, was diagnosed with hepatic neoplasm malignant, thrombosis and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. TARCEVA dosage: unknown. During the same period patient was treated with GEMZAR, OXALIPLATIN, COUMADIN. Patient died on 05/26/2007.
Tarceva Side Effects Report #5379526-2
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on June 18, 2007. Female patient, 57 years of age, was diagnosed with breast cancer, non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blepharitis, blepharospasm, dry eye, dry skin, eye pain, glare, hair colour changes, madarosis. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with NAVELBINE, FEMARA. Patient recovered.
Tarceva Side Effects Report #5379997-1
TARCEVA problem was reported by a Physician from SWITZERLAND on June 18, 2007. Male patient, 99 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cerebral disorder, cerebral haemorrhage, coagulopathy, neoplasm progression, thrombocytopenia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with LOW MOLECULAR HEPARIN. Patient died on 10/12/2006.
Tarceva Side Effects Report #5381823-1
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on June 19, 2007. Female patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, fall, malignant neoplasm progression, oedema peripheral, rash, subarachnoid haemorrhage. TARCEVA dosage: 100 MG QD, ORAL. During the same period patient was treated with PROTONIX, NORVASC, RASAGILINE, LASIX, MEMANTINE, CLINDAMYCIN OINTMENT. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5381879-6
TARCEVA problem was reported by a Health Professional from UNITED STATES on June 19, 2007. Female patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: small intestinal obstruction. TARCEVA dosage: 50 MG (QD) ORAL. Patient was hospitalized. Patient died on 06/19/2007.
Tarceva Side Effects Report #5382130-3
Physician from BELGIUM reported TARCEVA problem on June 20, 2007. Male patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, mucosal inflammation, muscle spasms, rash. TARCEVA dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5382131-5
TARCEVA problem was reported by a Health Professional from UNITED KINGDOM on June 20, 2007. Male patient was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: candidiasis. TARCEVA dosage: unknown. Patient died.
Tarceva Side Effects Report #5385049-7
Health Professional from UNITED STATES reported TARCEVA problem on July 10, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: abasia, cardiac failure, haemoglobin decreased. TARCEVA dosage: 150MG QD PO. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5385176-4
TARCEVA problem was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: accident, haemoptysis, malaise. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5385177-6
Physician from UNITED KINGDOM reported TARCEVA problem on June 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: accident, haemoptysis, malaise. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5385595-6
TARCEVA problem was reported by a Physician from CHINA on June 25, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cough, cyanosis, dyspnoea, haemoptysis, pyrexia, respiratory failure, white blood cell count increased. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5385596-8
Physician from ITALY reported TARCEVA problem on June 25, 2007. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea, heart rate increased, malignant pleural effusion, metastasis, superior vena caval occlusion, syncope, vena cava thrombosis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5388550-5
TARCEVA problem was reported by a Physician from FRANCE on June 26, 2007. Male patient, 68 years of age, was diagnosed with metastatic bronchial carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, ulcer haemorrhage. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTIVITAMIN K. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5388551-7
Physician from GERMANY reported TARCEVA problem on June 26, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: type 2 diabetes mellitus. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5389617-8
TARCEVA problem was reported by a Physician from ARGENTINA on June 28, 2007. Female patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: asthenia, disease progression, dyspepsia, pneumonia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient died.
Tarceva Side Effects Report #5391730-6
Physician from FRANCE reported TARCEVA problem on July 02, 2007. Male patient, 72 years of age, was diagnosed with lung cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: uveitis. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with TENORMIN, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5391732-X
TARCEVA problem was reported by a Physician from GERMANY on July 02, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: disease progression, type 1 diabetes mellitus. TARCEVA dosage: unknown. During the same period patient was treated with GEMCITABINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5392063-4
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on July 18, 2007. Female patient, 66 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: alveolitis allergic. TARCEVA dosage: 100MG PO QD. Patient recovered.
Tarceva Side Effects Report #5394873-6
TARCEVA problem was reported by a Physician from CHINA on July 05, 2007. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, haemoptysis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5394875-X
Physician from CHINA reported TARCEVA problem on July 05, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haemoptysis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5397298-2
TARCEVA problem was reported by a Physician from FRANCE on June 04, 2007. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, erythema multiforme, gamma-glutamyltransferase increased, inflammation, renal failure, transaminases increased. TARCEVA dosage: 150 MG (QD); ORAL. During the same period patient was treated with IMMUNOSUPPRESSANT NOS. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5399922-7
Physician from SINGAPORE reported TARCEVA problem on July 09, 2007. Male patient, 47 years of age, was diagnosed with lung adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, inflammation, pleural effusion, pyrexia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient recovered.
Tarceva Side Effects Report #5399925-2
TARCEVA problem was reported by a Physician from KOREA, REPUBLIC OF on July 09, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with MEGESTROL ACETATE, MYCHOPHENOLIC ACID, ALFUZOSIN, DEFLAZACORT. Patient died on 12/11/2006.
Tarceva Side Effects Report #5400101-5
Physician from KOREA, REPUBLIC OF reported TARCEVA problem on July 10, 2007. Male patient, 20 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with CODEINE SUL, DEXTROMETHORPHAN HYDROBROMIDE, TAZOCIN, CIPROFLOXACIN. Patient died on 12/03/2006.
Tarceva Side Effects Report #5400103-9
TARCEVA problem was reported by a Physician from FRANCE on July 10, 2007. Male patient, 49 years of age, was diagnosed with bronchial carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis, rash, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient died on 06/26/2007.
Tarceva Side Effects Report #5400189-1
Health Professional from UNITED STATES reported TARCEVA problem on July 27, 2007. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: muscular weakness, pyrexia. TARCEVA dosage: 400 MG DAILY ORAL. During the same period patient was treated with RAPAMUNE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5401300-9
TARCEVA problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Female patient, 91 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. TARCEVA dosage: 100 MG (QD), ORAL. Patient died on 06/20/2007.
Tarceva Side Effects Report #5402023-2
Physician from SPAIN reported TARCEVA problem on July 11, 2007. Male patient was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspepsia, dysphagia, faeces discoloured, musculoskeletal stiffness. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with ACETAMINOPHEN, TRAMADOL, KONAKION, TIRODRIL, OMEPRAZOLE, FORTECORTIN. Patient recovered.
Tarceva Side Effects Report #5402033-5
TARCEVA problem was reported by a Consumer or non-health professional from CANADA on July 12, 2007. Male patient, 56 years of age, was treated with TARCEVA. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5402817-3
Consumer or non-health professional from CHINA reported TARCEVA problem on July 13, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5403258-5
TARCEVA problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Female patient, 56 years of age, was diagnosed with breast cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: asthenia, weight decreased. TARCEVA dosage: 100 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5404264-7
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on July 16, 2007. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. TARCEVA dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMZAR, BENADRYL, DECADRON, REGLAN. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5404693-1
TARCEVA problem was reported by a Health Professional from CANADA on July 16, 2007. Female patient, 44 years of age, was treated with TARCEVA. TARCEVA dosage: 150 MG (QD), ORAL. Patient died on 06/04/2007.
Tarceva Side Effects Report #5404694-3
Physician from GREECE reported TARCEVA problem on July 24, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. TARCEVA dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient recovered.
Tarceva Side Effects Report #5376145-9
TARCEVA problem was reported by a Physician from UNITED STATES on June 28, 2007. Male patient, 68 years of age, was diagnosed with hepatic neoplasm malignant, thrombosis and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. TARCEVA dosage: unknown. During the same period patient was treated with GEMZAR, OXALIPLATIN, COUMADIN. Patient died on 05/26/2007.
Tarceva Side Effects Report #5379526-2
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on June 18, 2007. Female patient, 57 years of age, was diagnosed with breast cancer, non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blepharitis, blepharospasm, dry eye, dry skin, eye pain, glare, hair colour changes, madarosis. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with NAVELBINE, FEMARA. Patient recovered.
Tarceva Side Effects Report #5379997-1
TARCEVA problem was reported by a Physician from SWITZERLAND on June 18, 2007. Male patient, 99 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cerebral disorder, cerebral haemorrhage, coagulopathy, neoplasm progression, thrombocytopenia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with LOW MOLECULAR HEPARIN. Patient died on 10/12/2006.
Tarceva Side Effects Report #5381823-1
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on June 19, 2007. Female patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: abdominal pain, fall, malignant neoplasm progression, oedema peripheral, rash, subarachnoid haemorrhage. TARCEVA dosage: 100 MG QD, ORAL. During the same period patient was treated with PROTONIX, NORVASC, RASAGILINE, LASIX, MEMANTINE, CLINDAMYCIN OINTMENT. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5381879-6
TARCEVA problem was reported by a Health Professional from UNITED STATES on June 19, 2007. Female patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: small intestinal obstruction. TARCEVA dosage: 50 MG (QD) ORAL. Patient was hospitalized. Patient died on 06/19/2007.
Tarceva Side Effects Report #5382130-3
Physician from BELGIUM reported TARCEVA problem on June 20, 2007. Male patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, mucosal inflammation, muscle spasms, rash. TARCEVA dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5382131-5
TARCEVA problem was reported by a Health Professional from UNITED KINGDOM on June 20, 2007. Male patient was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: candidiasis. TARCEVA dosage: unknown. Patient died.
Tarceva Side Effects Report #5385049-7
Health Professional from UNITED STATES reported TARCEVA problem on July 10, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: abasia, cardiac failure, haemoglobin decreased. TARCEVA dosage: 150MG QD PO. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5385176-4
TARCEVA problem was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: accident, haemoptysis, malaise. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5385177-6
Physician from UNITED KINGDOM reported TARCEVA problem on June 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: accident, haemoptysis, malaise. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5385595-6
TARCEVA problem was reported by a Physician from CHINA on June 25, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cough, cyanosis, dyspnoea, haemoptysis, pyrexia, respiratory failure, white blood cell count increased. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5385596-8
Physician from ITALY reported TARCEVA problem on June 25, 2007. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea, heart rate increased, malignant pleural effusion, metastasis, superior vena caval occlusion, syncope, vena cava thrombosis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5388550-5
TARCEVA problem was reported by a Physician from FRANCE on June 26, 2007. Male patient, 68 years of age, was diagnosed with metastatic bronchial carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, ulcer haemorrhage. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTIVITAMIN K. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5388551-7
Physician from GERMANY reported TARCEVA problem on June 26, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: type 2 diabetes mellitus. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5389617-8
TARCEVA problem was reported by a Physician from ARGENTINA on June 28, 2007. Female patient, 61 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: asthenia, disease progression, dyspepsia, pneumonia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient died.
Tarceva Side Effects Report #5391730-6
Physician from FRANCE reported TARCEVA problem on July 02, 2007. Male patient, 72 years of age, was diagnosed with lung cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: uveitis. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with TENORMIN, PRAVASTATIN. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5391732-X
TARCEVA problem was reported by a Physician from GERMANY on July 02, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: disease progression, type 1 diabetes mellitus. TARCEVA dosage: unknown. During the same period patient was treated with GEMCITABINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5392063-4
Consumer or non-health professional from UNITED STATES reported TARCEVA problem on July 18, 2007. Female patient, 66 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: alveolitis allergic. TARCEVA dosage: 100MG PO QD. Patient recovered.
Tarceva Side Effects Report #5394873-6
TARCEVA problem was reported by a Physician from CHINA on July 05, 2007. Male patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased, haemoptysis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5394875-X
Physician from CHINA reported TARCEVA problem on July 05, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haemoptysis. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5397298-2
TARCEVA problem was reported by a Physician from FRANCE on June 04, 2007. Male patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, erythema multiforme, gamma-glutamyltransferase increased, inflammation, renal failure, transaminases increased. TARCEVA dosage: 150 MG (QD); ORAL. During the same period patient was treated with IMMUNOSUPPRESSANT NOS. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5399922-7
Physician from SINGAPORE reported TARCEVA problem on July 09, 2007. Male patient, 47 years of age, was diagnosed with lung adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, inflammation, pleural effusion, pyrexia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient recovered.
Tarceva Side Effects Report #5399925-2
TARCEVA problem was reported by a Physician from KOREA, REPUBLIC OF on July 09, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with MEGESTROL ACETATE, MYCHOPHENOLIC ACID, ALFUZOSIN, DEFLAZACORT. Patient died on 12/11/2006.
Tarceva Side Effects Report #5400101-5
Physician from KOREA, REPUBLIC OF reported TARCEVA problem on July 10, 2007. Male patient, 20 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspnoea. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with CODEINE SUL, DEXTROMETHORPHAN HYDROBROMIDE, TAZOCIN, CIPROFLOXACIN. Patient died on 12/03/2006.
Tarceva Side Effects Report #5400103-9
TARCEVA problem was reported by a Physician from FRANCE on July 10, 2007. Male patient, 49 years of age, was diagnosed with bronchial carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary fibrosis, rash, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient died on 06/26/2007.
Tarceva Side Effects Report #5400189-1
Health Professional from UNITED STATES reported TARCEVA problem on July 27, 2007. Male patient, weighting 185.2 lb, was diagnosed with glioblastoma multiforme and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: muscular weakness, pyrexia. TARCEVA dosage: 400 MG DAILY ORAL. During the same period patient was treated with RAPAMUNE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5401300-9
TARCEVA problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Female patient, 91 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. TARCEVA dosage: 100 MG (QD), ORAL. Patient died on 06/20/2007.
Tarceva Side Effects Report #5402023-2
Physician from SPAIN reported TARCEVA problem on July 11, 2007. Male patient was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dyspepsia, dysphagia, faeces discoloured, musculoskeletal stiffness. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with ACETAMINOPHEN, TRAMADOL, KONAKION, TIRODRIL, OMEPRAZOLE, FORTECORTIN. Patient recovered.
Tarceva Side Effects Report #5402033-5
TARCEVA problem was reported by a Consumer or non-health professional from CANADA on July 12, 2007. Male patient, 56 years of age, was treated with TARCEVA. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5402817-3
Consumer or non-health professional from CHINA reported TARCEVA problem on July 13, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5403258-5
TARCEVA problem was reported by a Consumer or non-health professional from UNITED STATES on July 12, 2007. Female patient, 56 years of age, was diagnosed with breast cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: asthenia, weight decreased. TARCEVA dosage: 100 MG (QD), ORAL. Patient died.
< Previous Showing 201-300 of 303 Next >